المؤلفون: Fouad A; Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, Connecticut, USA., Berry A; Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, Connecticut, USA., Gates J; Division of Acute Care Surgery, Hartford Hospital, Hartford, Connecticut, USA.; Department of Surgery, University of Connecticut School of Medicine, Farmington, Connecticut, USA., Kuti JL; Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, Connecticut, USA., Keating JJ; Division of Acute Care Surgery, Hartford Hospital, Hartford, Connecticut, USA.; Department of Surgery, University of Connecticut School of Medicine, Farmington, Connecticut, USA.

المصدر: Surgical infections [Surg Infect (Larchmt)] 2024 Aug; Vol. 25 (6), pp. 436-443. Date of Electronic Publication: 2024 Jul 12.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9815642 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-8674 (Electronic) Linking ISSN: 10962964 NLM ISO Abbreviation: Surg Infect (Larchmt) Subsets: MEDLINE

مواضيع طبية MeSH: Cefazolin*/pharmacokinetics , Cefazolin*/administration & dosage , Anti-Bacterial Agents*/pharmacokinetics , Anti-Bacterial Agents*/administration & dosage , Wounds and Injuries*/complications , Wounds and Injuries*/therapy, Humans ; Male ; Middle Aged ; Adult ; Female ; Aged ; Resuscitation/methods ; Antibiotic Prophylaxis/methods ; Young Adult

المؤلفون: Tsoulis MW; Department of Medicine, Dartmouth Hitchcock Medical Center, 1 Medical Center Drive Lebanon, NH 03756, USA., Hsu Blatman KS; Department of Medicine, Dartmouth Hitchcock Medical Center, 1 Medical Center Drive Lebanon, NH 03756, USA; Section of Allergy and Clinical Immunology, Dartmouth Hitchcock Medical Center, 1 Medical Center Drive, Lebanon, NH 03756, USA; Geisel School of Medicine at Dartmouth, 1 Rope Ferry Rd, Hanover, NH 03755, USA., Chow VW; Geisel School of Medicine at Dartmouth, 1 Rope Ferry Rd, Hanover, NH 03755, USA; Department of Anesthesiology, Dartmouth Hitchcock Medical Center, 1 Medical Center Drive, Lebanon, NH 03756, USA., Stewart KO; The Dartmouth Institute for Health Policy and Clinical Practice, 1 Medical Center Drive, Lebanon, NH 03766, USA; Collaborative Healthcare-associated Infection Prevention Program, Dartmouth Hitchcock Medical Center, 1 Medical Center Drive, Lebanon, NH 03756, USA., Wang R; Department of Medicine, Dartmouth Hitchcock Medical Center, 1 Medical Center Drive Lebanon, NH 03756, USA; Geisel School of Medicine at Dartmouth, 1 Rope Ferry Rd, Hanover, NH 03755, USA; The Dartmouth Institute for Health Policy and Clinical Practice, 1 Medical Center Drive, Lebanon, NH 03766, USA; Section of Infectious Disease and International Health, Dartmouth Hitchcock Medical Center, 1 Medical Center Drive, Lebanon, NH 03756, USA., Reigh EL; Department of Medicine, Dartmouth Hitchcock Medical Center, 1 Medical Center Drive Lebanon, NH 03756, USA; Section of Allergy and Clinical Immunology, Dartmouth Hitchcock Medical Center, 1 Medical Center Drive, Lebanon, NH 03756, USA; Geisel School of Medicine at Dartmouth, 1 Rope Ferry Rd, Hanover, NH 03755, USA. Electronic address: Erin.L.Reigh@hitchcock.org.

المصدر: Journal of clinical anesthesia [J Clin Anesth] 2024 Aug; Vol. 95, pp. 111443. Date of Electronic Publication: 2024 Mar 13.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 8812166 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4529 (Electronic) Linking ISSN: 09528180 NLM ISO Abbreviation: J Clin Anesth Subsets: MEDLINE

مواضيع طبية MeSH: Cefazolin*/adverse effects , Cefazolin*/administration & dosage , Drug Hypersensitivity*/prevention & control , Drug Hypersensitivity*/etiology , Drug Hypersensitivity*/epidemiology , Drug Hypersensitivity*/diagnosis , Penicillins*/adverse effects , Anti-Bacterial Agents*/adverse effects , Anti-Bacterial Agents*/administration & dosage , Antibiotic Prophylaxis*/adverse effects , Antibiotic Prophylaxis*/methods, Humans ; Female ; Male ; Aged ; Middle Aged ; Risk Assessment/methods ; Preoperative Care/methods ; Quality Improvement ; Perioperative Care/methods

المؤلفون: Eelsing R; Department of Surgery, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands.; Amsterdam Movement Sciences, AMS - Musculoskeletal Health, Amsterdam, the Netherlands., Penning D; Department of Surgery, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands.; Amsterdam Movement Sciences, AMS - Musculoskeletal Health, Amsterdam, the Netherlands., Vos-van der Meer M; Pharmacy laboratory, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands., Hodiamont CJ; Department of Medical Microbiology, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands., Mathôt RAA; Hospital Pharmacy and Clinical Pharmacology, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands., Schepers T; Department of Surgery, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands.; Amsterdam Movement Sciences, AMS - Musculoskeletal Health, Amsterdam, the Netherlands.

المصدر: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2024 Jul 09; Vol. 68 (7), pp. e0049424. Date of Electronic Publication: 2024 May 21.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-6596 (Electronic) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE

مواضيع طبية MeSH: Cefazolin*/pharmacokinetics , Cefazolin*/blood , Cefazolin*/administration & dosage , Cefazolin*/therapeutic use , Anti-Bacterial Agents*/pharmacokinetics , Anti-Bacterial Agents*/blood , Anti-Bacterial Agents*/administration & dosage , Anti-Bacterial Agents*/therapeutic use , Surgical Wound Infection*/prevention & control , Lower Extremity*/surgery , Antibiotic Prophylaxis*/methods, Humans ; Male ; Middle Aged ; Adult ; Female ; Prospective Studies ; Aged

المؤلفون: Komatsu T; Department of Pharmacy, Kitasato University Hospital, Kanagawa, Japan., Kawai Y; Pharmacy Practice and Science I, Research and Education Center for Clinical Pharmacy, Kitasato University School of Pharmacy, Kanagawa, Japan., Takayama Y; Department of Infection Control and Infectious Diseases, Research and Development Center for New Medical Frontiers, Kitasato University School of Medicine, Kanagawa, Japan., Akamada Y; Department of Pharmacy, Kitasato University Hospital, Kanagawa, Japan., Kusume E; Department of Pharmacy, Kitasato University Hospital, Kanagawa, Japan., Ikeda M; Department of Urology, Kitasato University of Medicine, Kanagawa, Japan., Tsumura H; Department of Urology, Kitasato University of Medicine, Kanagawa, Japan., Ishii D; Department of Urology, Kitasato University of Medicine, Kanagawa, Japan., Iwamura M; Department of Urology, Kitasato University of Medicine, Kanagawa, Japan., Okamoto H; Department of Anesthesiology, Kitasato University School of Medicine, Kanagawa, Japan., Hanaki H; Infection Control Research Center, Kitasato Institute for Life Sciences, Kitasato University, Tokyo, Japan., Otori K; Pharmacy Practice and Science I, Research and Education Center for Clinical Pharmacy, Kitasato University School of Pharmacy, Kanagawa, Japan.

المصدر: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2024 Jul 09; Vol. 68 (7), pp. e0026724. Date of Electronic Publication: 2024 May 21.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-6596 (Electronic) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE

مواضيع طبية MeSH: Cefazolin*/pharmacokinetics , Cefazolin*/blood , Cefazolin*/therapeutic use , Anti-Bacterial Agents*/pharmacokinetics , Anti-Bacterial Agents*/blood , Anti-Bacterial Agents*/pharmacology , Anti-Bacterial Agents*/therapeutic use , Nephrectomy* , Microbial Sensitivity Tests* , Prostatectomy* , Escherichia coli*/drug effects, Humans ; Male ; Middle Aged ; Aged ; Female ; Staphylococcus aureus/drug effects ; Adult ; Protein Binding ; Aged, 80 and over

المؤلفون: Wombwell E; University of Missouri-Kansas City School of Pharmacy, Kansas City, Missouri, USA; Centerpoint Medical Center, Independence, Missouri, USA. Electronic address: WombwellE@umsystem.edu., Rosa A; Centerpoint Medical Center, Independence, Missouri, USA.

المصدر: Clinical therapeutics [Clin Ther] 2024 Jun; Vol. 46 (6), pp. 451-454. Date of Electronic Publication: 2024 Mar 28.

نوع المنشور: Journal Article; Comparative Study; Observational Study

بيانات الدورية: Publisher: Excerpta Medica Country of Publication: United States NLM ID: 7706726 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-114X (Electronic) Linking ISSN: 01492918 NLM ISO Abbreviation: Clin Ther Subsets: MEDLINE

مواضيع طبية MeSH: Cefazolin*/therapeutic use , Cefazolin*/adverse effects , Urinary Tract Infections*/drug therapy , Urinary Tract Infections*/microbiology , Urinary Tract Infections*/epidemiology , Ceftriaxone*/adverse effects , Ceftriaxone*/therapeutic use , Anti-Bacterial Agents*/adverse effects , Anti-Bacterial Agents*/therapeutic use , Clostridium Infections*/microbiology , Clostridium Infections*/drug therapy , Clostridium Infections*/epidemiology , Microbial Sensitivity Tests*, Humans ; Retrospective Studies ; Male ; Female ; Middle Aged ; Aged ; Cross Infection/drug therapy ; Cross Infection/microbiology ; Cross Infection/epidemiology ; Inpatients ; Enterobacteriaceae/drug effects ; Enterobacteriaceae/isolation & purification ; Adult ; Clostridioides difficile/drug effects ; Clostridioides difficile/isolation & purification

المؤلفون: Laguna JJ; Allergy Unit, Allergo-Anaesthesia Unit, Hospital Universitario de la Cruz Roja, Faculty of Medicine, Alfonso X El Sabio University, ARADyAL, REI, Madrid, Spain. Electronic address: josejuliolaguna@gmail.com.

المصدر: Anaesthesia, critical care & pain medicine [Anaesth Crit Care Pain Med] 2024 Jun; Vol. 43 (3), pp. 101375. Date of Electronic Publication: 2024 Mar 12.

نوع المنشور: Editorial

بيانات الدورية: Publisher: Published by Elsevier Masson SAS on behalf of the Société française d'anesthésie et de réanimation (Sfar) Country of Publication: France NLM ID: 101652401 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-5568 (Electronic) Linking ISSN: 23525568 NLM ISO Abbreviation: Anaesth Crit Care Pain Med Subsets: MEDLINE

مواضيع طبية MeSH: Drug Hypersensitivity*/prevention & control , Drug Hypersensitivity*/etiology , Anti-Bacterial Agents*/adverse effects , Anti-Bacterial Agents*/therapeutic use , Antibiotic Prophylaxis*/methods , Cefazolin*/therapeutic use , Cefazolin*/adverse effects , Perioperative Care*/methods, Humans ; Surgical Wound Infection/prevention & control

المؤلفون: O'Hanlon CJ; Department of Pharmacology & Clinical Pharmacology, University of Auckland, Auckland, New Zealand., Holford N; Department of Pharmacology & Clinical Pharmacology, University of Auckland, Auckland, New Zealand., Anderson BJ; Department of Anaesthesiology, University of Auckland, Auckland, New Zealand.; Department of Anaesthesia, Auckland City Hospital, Auckland, New Zealand., Greaves M; Department of Anaesthesia, Auckland City Hospital, Auckland, New Zealand., Blackburn L; Department of Anaesthesiology, University of Auckland, Auckland, New Zealand., Tingle MD; Department of Pharmacology & Clinical Pharmacology, University of Auckland, Auckland, New Zealand., Hannam JA; Department of Pharmacology & Clinical Pharmacology, University of Auckland, Auckland, New Zealand.

المصدر: CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2024 Aug; Vol. 13 (8), pp. 1409-1421. Date of Electronic Publication: 2024 May 30.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 101580011 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2163-8306 (Electronic) Linking ISSN: 21638306 NLM ISO Abbreviation: CPT Pharmacometrics Syst Pharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Cefazolin*/pharmacokinetics , Cefazolin*/administration & dosage , Cardiopulmonary Bypass* , Anti-Bacterial Agents*/pharmacokinetics , Anti-Bacterial Agents*/administration & dosage, Humans ; Adsorption ; Infant ; Adult ; Child ; Infant, Newborn

المؤلفون: Destrem AL; Infectious Diseases Department, Centre Hospitalier Métropole Savoie, Chambéry, France., Maillard A; Infectious Diseases Department, Pitié-Salpêtrière University Hospital, Paris, France., Simonet M; Infectious Diseases Department, Centre Hospitalier Annecy Genevois, Annecy, France., Simeon S; Infectious Diseases Department, Henri Mondor University Hospital, Paris, France., Contejean A; Infectious Diseases Department, Cochin University Hospital, Paris, France.; Hematology Department, Centre Hospitalier Annecy Genevois, Annecy, France., Vignau C; Infectious Diseases Department, Grenoble University Hospital, Grenoble, France., Pires L; Clinical Research Unit, Centre Hospitalier Annecy Genevois, Annecy, France., Isnard M; Infectious Diseases Department, Centre Hospitalier Métropole Savoie, Chambéry, France., Vitrat V; Infectious Diseases Department, Centre Hospitalier Annecy Genevois, Annecy, France., Delory T; Clinical Research Unit, Centre Hospitalier Annecy Genevois, Annecy, France., Maillet M; Infectious Diseases Department, Centre Hospitalier Annecy Genevois, Annecy, France. mmaillet@ch-annecygenevois.fr.

المصدر: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology [Eur J Clin Microbiol Infect Dis] 2024 Aug; Vol. 43 (8), pp. 1569-1577. Date of Electronic Publication: 2024 May 28.

نوع المنشور: Journal Article; Multicenter Study; Comparative Study

بيانات الدورية: Publisher: Springer Country of Publication: Germany NLM ID: 8804297 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1435-4373 (Electronic) Linking ISSN: 09349723 NLM ISO Abbreviation: Eur J Clin Microbiol Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: Cefazolin*/therapeutic use , Cloxacillin*/therapeutic use , Cloxacillin*/adverse effects , Anti-Bacterial Agents*/therapeutic use , Anti-Bacterial Agents*/adverse effects , Endocarditis, Bacterial*/drug therapy , Endocarditis, Bacterial*/microbiology , Endocarditis, Bacterial*/mortality , Staphylococcal Infections*/drug therapy , Staphylococcal Infections*/microbiology , Staphylococcal Infections*/mortality, Humans ; Aged ; Male ; Female ; Retrospective Studies ; Middle Aged ; Treatment Outcome ; Staphylococcus/drug effects ; Propensity Score ; France ; Aged, 80 and over

المؤلفون: Yo DJ; Brigham and Women's Hospital, Department of Anesthesiology, Perioperative and Pain Medicine, Harvard Medical School, Boston, MA, United States of America., Urman RD; Department of Anesthesiology, The Ohio State University, Columbus, OH, United States of America. Electronic address: urmanr@gmail.com., Pimentel MPT; Brigham and Women's Hospital, Department of Anesthesiology, Perioperative and Pain Medicine, Harvard Medical School, Boston, MA, United States of America.

المصدر: Journal of clinical anesthesia [J Clin Anesth] 2024 Aug; Vol. 95, pp. 111431. Date of Electronic Publication: 2024 Mar 10.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 8812166 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4529 (Electronic) Linking ISSN: 09528180 NLM ISO Abbreviation: J Clin Anesth Subsets: MEDLINE

مواضيع طبية MeSH: Drug Hypersensitivity*/etiology , Drug Hypersensitivity*/diagnosis , Cefazolin*/adverse effects , Cefazolin*/administration & dosage , Anti-Bacterial Agents*/adverse effects , Anti-Bacterial Agents*/administration & dosage , Penicillins*/adverse effects , Penicillins*/administration & dosage, Humans ; Drug Labeling

المؤلفون: Petersiel N; Victorian Infectious Diseases Service, The Royal Melbourne Hospital, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.; Department of Infectious Diseases, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia., Giulieri S; Victorian Infectious Diseases Service, The Royal Melbourne Hospital, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.; Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia., Daniel DS; Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.; Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology, University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia., Fan S-H; The Lundquist Institute for Biomedical Innovation, Torrance, California, USA., Ersoy SC; The Lundquist Institute for Biomedical Innovation, Torrance, California, USA., Davis JS; Menzies School of Health Research and Charles Darwin University, Darwin, Northern Territory, Australia.; Department of Infectious Diseases, John Hunter Hospital, Newcastle, New South Wales, Australia., Bayer AS; The Lundquist Institute for Biomedical Innovation, Torrance, California, USA.; The Geffen School of Medicine, University of California, Los Angeles, California, USA., Howden BP; Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.; Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology, University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.; Centre for Pathogen Genomics, The University of Melbourne, Melbourne, Victoria, Australia.; Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia., Tong SYC; Victorian Infectious Diseases Service, The Royal Melbourne Hospital, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.; Department of Infectious Diseases, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.

مؤلفون مشاركون: CAMERA2 study group

المصدر: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2024 Jul 09; Vol. 68 (7), pp. e0021824. Date of Electronic Publication: 2024 Jun 05.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-6596 (Electronic) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE

مواضيع طبية MeSH: Methicillin-Resistant Staphylococcus aureus*/drug effects , Methicillin-Resistant Staphylococcus aureus*/genetics , Microbial Sensitivity Tests* , Anti-Bacterial Agents*/pharmacology , Anti-Bacterial Agents*/therapeutic use , Cefazolin*/pharmacology , Cefazolin*/therapeutic use , Staphylococcal Infections*/drug therapy , Staphylococcal Infections*/microbiology , Oxacillin*/pharmacology, Humans ; Bacteremia/drug therapy ; Bacteremia/microbiology ; Phenotype ; beta-Lactams/pharmacology ; beta-Lactams/therapeutic use ; Male ; Sodium Bicarbonate/pharmacology ; Female ; Middle Aged